Literature DB >> 31029510

Multidisciplinary care in tenosynovial giant cell tumours.

William D Tap1.   

Abstract

Entities:  

Year:  2019        PMID： 31029510     DOI： 10.1016/S1470-2045(19)30173-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors.

Authors:  James H Lewis; Hans Gelderblom; Michiel van de Sande; Silvia Stacchiotti; John H Healey; William D Tap; Andrew J Wagner; Antonio Lopez Pousa; Mihaela Druta; Chia-Chi Lin; Hideo A Baba; Youngsook Choi; Qiang Wang; Dale E Shuster; Sebastian Bauer
Journal:  Oncologist       Date:  2020-12-24

2.  Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas.

Authors:  Lauren H Boal; John Glod; Melissa Spencer; Miki Kasai; Joanne Derdak; Eva Dombi; Mark Ahlman; Daniel W Beury; Melinda S Merchant; Christianne Persenaire; David J Liewehr; Seth M Steinberg; Brigitte C Widemann; Rosandra N Kaplan
Journal:  Clin Cancer Res       Date:  2020-09-17       Impact factor: 13.801
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.